Diagnosing gastrointestinal illnesses using fecal headspace volatile organic compounds.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 26819529)

Published in World J Gastroenterol on January 28, 2016

Authors

Daniel K Chan1, Cadman L Leggett1, Kenneth K Wang1

Author Affiliations

1: Daniel K Chan, Cadman L Leggett, Kenneth K Wang, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, United States.

Articles cited by this

Gas-liquid partition chromatography; the separation and micro-estimation of volatile fatty acids from formic acid to dodecanoic acid. Biochem J (1952) 17.26

Exhaled volatile organic compounds identify patients with colorectal cancer. Br J Surg (2013) 3.50

Olfactory detection of human bladder cancer by dogs: proof of principle study. BMJ (2004) 3.32

Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci U S A (1971) 3.14

Sniffer dogs in the melanoma clinic? Lancet (1989) 2.90

Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med (1997) 2.47

Does the nose know? The odiferous diagnosis of Clostridium difficile-associated diarrhea. Clin Infect Dis (2007) 2.42

Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer (2010) 2.35

Colorectal cancer screening with odour material by canine scent detection. Gut (2011) 2.23

Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol (2013) 2.20

Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther (2006) 2.15

An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer (2008) 1.80

Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J (2007) 1.77

Detection of obstructive sleep apnoea by an electronic nose. Eur Respir J (2012) 1.66

Advances in electronic-nose technologies developed for biomedical applications. Sensors (Basel) (2011) 1.66

Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis. PLoS One (2014) 1.44

An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol (2007) 1.40

Human ovarian carcinomas detected by specific odor. Integr Cancer Ther (2008) 1.37

Comparison of the canine and human olfactory receptor gene repertoires. Genome Biol (2003) 1.28

Recent advances in electronic and bioelectronic noses and their biomedical applications. Enzyme Microb Technol (2011) 1.14

Secondary electrospray ionization ion mobility spectrometry/mass spectrometry of illicit drugs. Anal Chem (2000) 1.08

Using a dog's superior olfactory sensitivity to identify Clostridium difficile in stools and patients: proof of principle study. BMJ (2012) 1.08

Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry. Br J Cancer (2011) 1.08

Different fecal microbiotas and volatile organic compounds in treated and untreated children with celiac disease. Appl Environ Microbiol (2009) 1.06

The detection of patients at risk of gastrointestinal toxicity during pelvic radiotherapy by electronic nose and FAIMS: a pilot study. Sensors (Basel) (2012) 1.05

Analysis of faecal volatile organic compounds in preterm infants who develop necrotising enterocolitis: a pilot study. J Pediatr Gastroenterol Nutr (2009) 1.04

Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study. Int J Cancer (2013) 1.02

A novel method for rapidly diagnosing the causes of diarrhoea. Gut (2004) 0.97

A pilot study of faecal volatile organic compounds in faeces from cholera patients in Bangladesh to determine their utility in disease diagnosis. Trans R Soc Trop Med Hyg (2009) 0.97

An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS One (2013) 0.97

Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis (2013) 0.97

Review article: next generation diagnostic modalities in gastroenterology--gas phase volatile compound biomarker detection. Aliment Pharmacol Ther (2014) 0.97

Clostridium difficile associated diarrhoea: how good are nurses at identifying the disease? Age Ageing (2002) 0.96

Ambient analysis of trace compounds in gaseous media by SIFT-MS. Analyst (2011) 0.96

On-line detection of human skin vapors. J Am Soc Mass Spectrom (2009) 0.96

Development of a novel method for detection of Clostridium difficile using HS-SPME-GC-MS. J Appl Microbiol (2014) 0.92

An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls. Lung Cancer (2011) 0.92

Biomarkers for early detection of colorectal cancer and polyps: systematic review. Cancer Epidemiol Biomarkers Prev (2014) 0.91

Clinical application of volatile organic compound analysis for detecting infectious diseases. Clin Microbiol Rev (2013) 0.89

The scent of colorectal cancer: detection by volatile organic compound analysis. Clin Gastroenterol Hepatol (2014) 0.86

Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose. Respirology (2011) 0.85

Detection of gastro-oesophageal reflux disease (GORD) in patients with obstructive lung disease using exhaled breath profiling. J Breath Res (2012) 0.84

Faecal gas analysis by electronic nose as novel, non-invasive method for assessment of active and quiescent paediatric inflammatory bowel disease: Proof of principle study. J Crohns Colitis (2014) 0.82

Differentiation between cerebrospinal fluid and serum with electronic nose. Otolaryngol Head Neck Surg (2005) 0.82

Blood volatile compounds as biomarkers for colorectal cancer. Cancer Biol Ther (2013) 0.82

[Comparison of four identical electronic noses and three measurement set-ups]. Pneumologie (2011) 0.81

Artificial odor discrimination system using electronic nose and neural networks for the identification of urinary tract infection. IEEE Trans Inf Technol Biomed (2008) 0.81

Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study. J Clin Microbiol (2013) 0.79

The use of a gas chromatograph coupled to a metal oxide sensor for rapid assessment of stool samples from irritable bowel syndrome and inflammatory bowel disease patients. J Breath Res (2014) 0.78

The Highs and Lows of FAIMS: Predictions and Future Trends for High Field Asymmetric Waveform Ion Mobility Spectrometry. J Nanomed Nanotechnol (2012) 0.77

The nose knows not: poor predictive value of stool sample odor for detection of Clostridium difficile. Clin Infect Dis (2012) 0.76